Suppressor of Hairless [Su(H)] is a transcriptional regulator integral to the Notch signaling pathway, a fundamental mechanism that orchestrates cell differentiation, proliferation, and fate determination across various tissues in both invertebrates and vertebrates. The protein functions as a transcriptional effector within this pathway, directly binding to DNA and regulating the expression of target genes pivotal for developmental processes and cellular communication. Su(H)'s role is underscored by its interaction with the Notch receptor's intracellular domain (NICD), which, upon activation, translocates to the nucleus. This translocation is essential for the assembly of a transcriptional activation complex, comprising Su(H), NICD, and other coactivators, that modulates the expression of genes involved in cell fate decisions. The specificity and versatility of Su(H) in gene regulation are further refined by its ability to interact with different cofactors, thereby dictating the transcriptional outcome based on the cellular context and the state of Notch signaling.
The activation of Suppressor of Hairless is intricately tied to the activation of the Notch receptor, which undergoes proteolytic cleavage in response to ligand engagement. This cleavage releases the NICD, which then enters the nucleus and associates with Su(H). This association marks a pivotal step in the activation process, transforming Su(H) from a repressor to an activator of transcription. The transition from repression to activation is facilitated by the displacement of corepressors and the recruitment of Mastermind-like (MAML) proteins and other coactivators to the transcriptional complex. This recruitment is critical for the assembly of a transcriptionally active complex on the DNA, enabling the precise regulation of Notch target genes. The dynamic regulation by Su(H), through its ability to switch between a repressor and an activator state, exemplifies the nuanced control mechanisms that underlie the Notch signaling pathway.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator. Activation of JNK by Anisomycin can lead to increased activity of the Notch pathway, thereby leading to increased Su(H) activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, which can increase cAMP levels. Elevated cAMP can activate Protein Kinase A (PKA), which can potentially phosphorylate and activate Su(H), thereby enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). PKC can phosphorylate and activate Su(H), thereby enhancing its activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, it prevents the dephosphorylation and inactivation of Su(H), thereby maintaining its activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK3-beta, which is a negative regulator of Su(H). By inhibiting GSK3-beta, Lithium Chloride can indirectly increase Su(H) activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterase (PDE), leading to increased levels of cAMP, which can activate PKA. PKA can potentially phosphorylate and activate Su(H), enhancing its activity. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR inhibitor, however, it can paradoxically increase Su(H) activity by inhibiting a negative regulator of the protein. | ||||||
Vismodegib | 879085-55-9 | sc-396759 sc-396759A | 10 mg 25 mg | $82.00 $158.00 | 1 | |
Vismodegib is a Hedgehog pathway inhibitor, but in the context of Su(H), it can increase its activity by inhibiting a negative regulator of the protein. | ||||||